Enhancing GLP-1 levels through dietary or probiotic strategies may offer a promising approach for managing metabolic diseases such as type 2 diabetes, obesity, and cardiovascular conditions. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.